NOX 5.00% 10.5¢ noxopharm limited

Beware the false prophet, page-14

  1. 4,947 Posts.
    lightbulb Created with Sketch. 790
    "26 July 800mg second efficacy scan (12 weeks)
    09 August Cohort 4 fully recruited (allow 4 weeks)
    23 August 1200mg second efficacy scan (12 weeks)
    06 September
    20 September Cohort 4 first efficacy scan
    The first efficacy scans should be complete before the mid-year briefing takes place. It looks to be an exciting year!" (RBX post 06/04/18)

    "I expect the first DARRT results to be announced in early August. (RBX 08/06/18)

    "And I should have worked out that even in a blinded study, hospitals and patients KNOW when they see great responses relative to standard outcomes; and that slow recruitment meant that no one was excited by results to date. " (RBX 10/05/18)

    "was so strict that over an extended period, only nine patients met the criteria. Treating oncologists said that one measurable lesion (rather than two) would be sufficient to achieve the study aim and would greatly increase the patient pool. The change was published once HREC approval had been obtained, so recruitment should quickly accelerate." (RBX yesterday)
    Last edited by harvett: 30/10/18
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.005(5.00%)
Mkt cap ! $29.22M
Open High Low Value Volume
10.0¢ 10.5¢ 10.0¢ $555 5.296K

Buyers (Bids)

No. Vol. Price($)
1 95000 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 151971 2
View Market Depth
Last trade - 15.18pm 22/11/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.